キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/02 | 3,795 | 3,830 | 3,775 | 3,795 | ±0 | ±0% | 75,200 |
2025/05/01 | 3,770 | 3,795 | 3,750 | 3,795 | +50 | +1.3% | 61,300 |
2025/04/30 | 3,750 | 3,755 | 3,705 | 3,745 | +45 | +1.2% | 76,800 |
2025/04/28 | 3,715 | 3,745 | 3,690 | 3,700 | -25 | -0.7% | 66,500 |
2025/04/25 | 3,780 | 3,795 | 3,720 | 3,725 | -50 | -1.3% | 38,900 |
2025/04/24 | 3,850 | 3,895 | 3,775 | 3,775 | -70 | -1.8% | 67,700 |
2025/04/23 | 3,850 | 3,860 | 3,815 | 3,845 | +10 | +0.3% | 58,200 |
2025/04/22 | 3,790 | 3,890 | 3,785 | 3,835 | +55 | +1.5% | 77,000 |
2025/04/21 | 3,730 | 3,795 | 3,715 | 3,780 | +70 | +1.9% | 58,800 |
2025/04/18 | 3,650 | 3,740 | 3,615 | 3,710 | +115 | +3.2% | 73,000 |
2025/04/17 | 3,580 | 3,600 | 3,560 | 3,595 | +15 | +0.4% | 47,600 |
2025/04/16 | 3,635 | 3,645 | 3,560 | 3,580 | -55 | -1.5% | 71,700 |
2025/04/15 | 3,650 | 3,670 | 3,630 | 3,635 | ±0 | ±0% | 38,900 |
2025/04/14 | 3,600 | 3,675 | 3,590 | 3,635 | +95 | +2.7% | 68,900 |
2025/04/11 | 3,540 | 3,550 | 3,480 | 3,540 | -135 | -3.7% | 86,000 |
2025/04/10 | 3,660 | 3,695 | 3,630 | 3,675 | +85 | +2.4% | 130,400 |
2025/04/09 | 3,595 | 3,680 | 3,560 | 3,590 | -60 | -1.6% | 107,600 |
2025/04/08 | 3,690 | 3,690 | 3,575 | 3,650 | +30 | +0.8% | 118,800 |
2025/04/07 | 3,505 | 3,715 | 3,505 | 3,620 | -95 | -2.6% | 194,300 |
2025/04/04 | 3,835 | 3,835 | 3,705 | 3,715 | -50 | -1.3% | 156,200 |
2025/04/03 | 3,645 | 3,800 | 3,630 | 3,765 | -5 | -0.1% | 101,300 |
2025/04/02 | 3,805 | 3,810 | 3,740 | 3,770 | -45 | -1.2% | 66,600 |
2025/04/01 | 3,865 | 3,865 | 3,805 | 3,815 | -30 | -0.8% | 63,300 |
2025/03/31 | 3,845 | 3,880 | 3,755 | 3,845 | -45 | -1.2% | 99,000 |
2025/03/28 | 3,930 | 3,940 | 3,875 | 3,890 | -45 | -1.1% | 88,900 |
2025/03/27 | 3,880 | 3,940 | 3,875 | 3,935 | +30 | +0.8% | 125,900 |
2025/03/26 | 3,865 | 3,910 | 3,855 | 3,905 | +25 | +0.6% | 78,300 |
2025/03/25 | 3,865 | 3,890 | 3,805 | 3,880 | +15 | +0.4% | 61,600 |
2025/03/24 | 3,840 | 3,880 | 3,825 | 3,865 | +40 | +1% | 53,200 |
2025/03/21 | 3,800 | 3,840 | 3,800 | 3,825 | -20 | -0.5% | 55,200 |
2025/03/19 | 3,755 | 3,860 | 3,755 | 3,845 | +20 | +0.5% | 83,700 |
2025/03/18 | 3,825 | 3,870 | 3,800 | 3,825 | +10 | +0.3% | 76,800 |
2025/03/17 | 3,750 | 3,815 | 3,695 | 3,815 | +50 | +1.3% | 60,200 |
2025/03/14 | 3,730 | 3,785 | 3,730 | 3,765 | ±0 | ±0% | 58,100 |
2025/03/13 | 3,710 | 3,800 | 3,705 | 3,765 | +65 | +1.8% | 69,300 |
2025/03/12 | 3,555 | 3,715 | 3,555 | 3,700 | +80 | +2.2% | 76,600 |
2025/03/11 | 3,640 | 3,660 | 3,565 | 3,620 | -45 | -1.2% | 93,600 |
2025/03/10 | 3,680 | 3,685 | 3,620 | 3,665 | -5 | -0.1% | 53,100 |
2025/03/07 | 3,685 | 3,700 | 3,650 | 3,670 | -50 | -1.3% | 45,700 |
2025/03/06 | 3,710 | 3,765 | 3,695 | 3,720 | +20 | +0.5% | 70,100 |
2025/03/05 | 3,710 | 3,750 | 3,670 | 3,700 | +45 | +1.2% | 65,300 |
2025/03/04 | 3,700 | 3,730 | 3,650 | 3,655 | -35 | -0.9% | 52,300 |
2025/03/03 | 3,735 | 3,745 | 3,690 | 3,690 | +10 | +0.3% | 47,500 |
2025/02/28 | 3,670 | 3,715 | 3,630 | 3,680 | +15 | +0.4% | 108,000 |
2025/02/27 | 3,650 | 3,675 | 3,625 | 3,665 | +45 | +1.2% | 64,500 |
2025/02/26 | 3,595 | 3,660 | 3,570 | 3,620 | -15 | -0.4% | 47,200 |
2025/02/25 | 3,570 | 3,650 | 3,545 | 3,635 | +45 | +1.3% | 82,900 |
2025/02/21 | 3,640 | 3,640 | 3,515 | 3,590 | -40 | -1.1% | 60,500 |
2025/02/20 | 3,595 | 3,700 | 3,595 | 3,630 | +30 | +0.8% | 77,900 |
2025/02/19 | 3,605 | 3,630 | 3,595 | 3,600 | -55 | -1.5% | 31,400 |
1~
50
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム